Evidence map›Paper›PMID 39012889›Full record

ArticlePloS one2024

Effectiveness of food supplement on treatment outcomes and quality of life in pulmonary tuberculosis: Phased implementation approach.

Amarendra Mahapatra, Kannan Thiruvengadam, Dina Nair, Chandrasekaran Padmapriyadarsini, Beena Thomas, Sanghamitra Pati, Gandham Bulliyya, Dasarathi Das, Jayeeta Chowdhury, Anand Bang and 1 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amarendra MahapatraICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.ORCID 0000-0001-6007-7294
Kannan ThiruvengadamICMR-National Institute for Research in Tuberculosis, Chennai, India.
Dina NairICMR-National Institute for Research in Tuberculosis, Chennai, India.
Chandrasekaran PadmapriyadarsiniICMR-National Institute for Research in Tuberculosis, Chennai, India.ORCID 0000-0002-1324-4595
Beena ThomasICMR-National Institute for Research in Tuberculosis, Chennai, India.
Sanghamitra PatiICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
Gandham BulliyyaICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
Dasarathi DasICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, India.
Jayeeta ChowdhuryTata Trusts, Mumbai, India.
Anand BangTata Trusts, Mumbai, India.
Soumya SwaminathanIndian Council of Medical Research, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBy encouraging treatment adherence and lowering mortality, dietary supplements can serve as adjuvant therapy for the success of medical interventions. We determined the effect of locally accessible food supplements on treatment outcomes, and health-related quality of life in patients with pulmonary tuberculosis initiating anti-tuberculosis treatment (ATT) in Odisha, India.

methodBetween September 2017 and December 2018, implementation research in patients with newly diagnosed sputum smear-positive pulmonary tuberculosis initiating ATT in five districts of the tribal belt of Odisha, offered food supplements along with ATT in a phased manner. Clinical symptoms, anthropometry, sputum for M. tuberculosis (M. tb), health-related quality of life and return to normal function were assessed periodically, and favourable treatment outcome (cure or treatment completed) was measured at the end of treatment. The effect of the food supplement on unfavorable outcomes (treatment failure, death, or lost-to-follow-up) was modelled using mixed-effects Poisson regression to determine the risk factors.

resultsAmong the 761 participants enrolled, 614 participants received the food supplement and 147 did not receive the food supplement. Among the 614 participants in the supplement group, 537 (87%) had a favorable outcome and among the 147 participants in the no-supplement group, 113 (77%) had a favorable outcome (p = 0.0017). Higher age (>55 years) [aRR = 2.1(95% CI: 1.1-3.8)], male gender [aRR = 1.7(95% CI: 1.2-2.9)], and smear grading ≥2+ [aRR = 1.5 (95% CI: 1.1-2.2)] were associated with unfavorable treatment outcomes. Nutritional status, quality of life and lung health showed significant improvement from baseline in the supplement group.

conclusionImprovement in the nutritional status of the patient can be considered a predictor of treatment success rates. Early food supplementation has a positive impact on the nutritional status.

Indexed as

Antitubercular AgentsDietary SupplementsQuality of LifeTuberculosis, PulmonaryAdultFemaleHumansIndiaMaleMiddle AgedTreatment OutcomeYoung AdultAntitubercular Agents

Identifiers

PMID39012889
PMCPMC11251611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.